bypass system (Terumo Inc, Tokyo, Japan) was used. All blood-contacting surfaces of both systems were coated with heparin. A 15Fr arterial cannula and a 21Fr venous cannula were inserted percutaneously into the femoral artery and vein, respectively, by puncture. IABP was used in all patients to reduce afterload. Intravenous heparin was used to maintain the activated clotting time at ≥150 s.
Echocardiography
Echocardiography was performed on admission, 1-4 days after admission (acute phase) and 12-20 months after admission (chronic phase). Initial echocardiograms for each patient were evaluated before inserting the PCPS. Follow-up echocardiograms were performed during the chronic phase in 12 survivors: 6 of the 8 patients in the PCPS group and all 6 patients in the non-PCPS group. For each echocardiogram, the left ventricular diastolic dimension (LVDd), left ventricular systolic dimension (LVDs), interventricular wall thickness (IVST) and posterior wall thickness (PWT) were measured by M-mode in the parasternal long-axis view using the leading edge to edge method. LVEF was calculated using a standard method. 9 
Statistical Analysis
All values are reported as mean ± standard deviation.
Differences between 2 groups in the acute phase were compared by Student's t-test. Two-way repeated measures ANOVA was used to assess the interaction between the type of myocarditis and changes in the acute and chronic phases, with time as the intrapatient variable and type of myocarditis as the interpatient variable (Statview 5.0, SAS institute Inc, Cary, NC, USA). A two-sided p-value <0.05 was considered to indicate statistical significance. A Kaplan-Meier survival curve was used to evaluate the prognosis of the patients in the 2 groups.
Results

Clinical Observations
The clinical characteristics of the 2 groups are shown in Table 1 . The indications for PCPS in the 8 patients were as follows: 6 had acute decompensation with rapid deterioration of cardiac function and 2 had malignant ventricular arrhythmias. Although there was no difference in age, sex or follow-up period between the 2 groups, life-threatening arrhythmia and atrioventricular block occurring during the clinical course were more common in the PCPS group. The maximum concentration of serum CK-MB in the acute phase was also higher in the PCPS group than in the non-PCPS group. 
Hemodynamics
On admission, patients requiring PCPS had significantly lower systemic blood pressure than the patients in the non-PCPS group. Pulse rates were significantly faster in the PCPS group and the stroke volume (SV) of the PCPS patients, measured by echocardiography before inserting the PCPS, was significantly less than that of the non-PCPS patients (Table 1) .
Specific Medical Therapy
All of the patients in the PCPS group needed both IABP and inotropic drugs ( Table 2 ). In the non-PCPS group, only 1 patient required IABP and all 6 needed inotropic agents. Three patients in the PCPS group were treated with methylprednisolone and 1 of them also required immunoglobulin. None of the non-PCPS group was treated with immunosuppressive agents. In the chronic phase, there was no difference between the 2 groups with regard to therapy.
Clinical Outcome
In the PCPS group 6 of the 8 patients (75%) survived the acute phase (2 deaths from cardiogenic shock, and mechanical complication (aortic dissection), respectively) and survived to the end of the follow-up period (range, 1.4-5.9 Kaplan-Meier survival curves of the percutaneous cardiopulmonary support (PCPS) group and non-PCPS group with fulminant myocarditis. In the PCPS group, 2 patients died within 10 days after admission, but none of the 6 surviving patients had cardiac symptoms during the follow-up period (range, 1.4-5.9 years). All the non-PCPS patients survived the acute phase and although 1 died from malignancy 4 years after discharge, the other 5 survived the follow-up period (range, 2.2-9.4 years). years), being classified as NYHA class I. None of the PCPS group had a cardiac problem after discharge and all of them survived the acute phase. One non-PCPS group patient had an episode of congestive heart failure because of chronic myocarditis 1.5 years after discharge and another died from malignancy 4 years after discharge, but there were no other deaths in the non-PCPS group during the follow-up period (range, 2.2-9.4 years) (Fig 1) .
Echocardiography
Echocardiographic measurements in the acute phase (0-3 days after admission) and the chronic phase (1.4-2.5 years after admission) are shown in Fig 2. In both groups, but especially the PCPS group, there was a significant decrease in LVEF in the acute phase (PCPS: 21.6±11.9%; non-PCPS: 26.3±6.8%). In the acute phase, the LV wall was more significantly thickened in the PCPS group than in the non-PCPS group (IVST/PWT: PCPS: 13.9±1.8/13.4± 2.9 mm; non-PCPS: 11.2±1.6/11.3±2.1 mm, p<0.05). The prevalence of pericardial effusion in the acute phase was also higher in the PCPS group than in the non-PCPS group (PCPS: 7/8 patients (87.5%); non-PCPS: 1/6 patients (16.7%), p<0.05). In the chronic phase, the LVEF of the PCPS group (57.8±4.2%) significantly improved compared with the acute phase. Although there was no significant difference in LVEF between the 2 groups in the chronic phase, normalization of LVEF (>50%) was more likely in the PCPS group (100%) than in the non-PCPS group (66.7%). LVDd did not increase significantly in either group from the acute phase to the chronic phase.
Discussion
The present study reports the long-term follow-up results of patients with fulminant myocarditis who were treated with or without PCPS. The LV dimensions of the PCPS group in the chronic phase did not show dilatation compared with the acute phase, although the PCPS group showed more deterioration in LV function, more thickening of the LV wall and more frequent pericardial effusion than the non-PCPS group in the acute phase. The data clearly shows a favorable long-term survival rate for patients who survive the acute phase crisis of acute myocarditis, whether or not mechanical support is used. Previously reported echocardiographic manifestations of fulminant myocarditis include global and regional systolic and diastolic dysfunction 2,5,6,10-12,14 and lack of LV dilatation. 2, 5, 6, 13, 14 Felker et al reported that 14 patients with fulminant myocarditis presented with non-dilated, thickened, hypocontractile ventricles in the acute phase, but showed significant improvement in LV contraction 6 months after discharge, 14 and their findings are generally consistent with ours, although none of their patients was treated with PCPS.
The present finding of a good recovery of LVEF without LV dilatation in the PCPS group suggests that the combination of PCPS and IABP inhibits remodeling of an inflamed LV by reducing preload and afterload during the acute phase. This hypothesis is supported by the findings of previous studies. Mendes et al reported that active myocarditis is associated with early LV remodeling and development of a spherical chamber. 15 They found that improvement of the LVEF is associated with a reduction in LV volume and restoration of a more elliptical chamber on the echocardiogram, which suggests that the remodeling process is reversible. Burkhoff et al reported that LV assist devices provide chronic pressure and volume unloading of the dilated left ventricle in patients with end-stage heart failure, 16 which is associated with reverse structural remodeling (normalization of the passive pressure -volume relationship), reverse molecular remodeling (increased expression of several genes involved in calcium metabolism that are down-regulated in heart failure), improved baseline contractility, and improved contractile response to increased heart rate and -agonist stimulation. In the chronic phase of the present patients, there was no significant difference in the medical therapy of the 2 groups. Although it is possible that changing the therapy of some patients in the non-PCPS group during the chronic phase could have prevented the reduction in cardiac function, we believe that the different medications had relatively little influence on cardiac remodeling.
Recent studies have reported that the SV may be used as a hemodynamic index of the severity of myocarditis. 17, 18 Morimoto et al reported that the reduction in SV in patients with acute myocarditis is probably caused by narrowing of the LV cavity associated with transient ventricular wall thickening 18 and our findings are generally consistent with this suggestion.
A long-term follow-up study by Dec et al 19 have that patients with acute myocarditis have a variable prognosis, with some patients regaining normal ventricular function and others progressing to dilated cardiomyopathy. However, there have been few reports of the long-term prognosis of fulminant myocarditis. McCarthy et al reported that patients with fulminant myocarditis have better long-term survival than those with acute myocarditis, 7 but they used the classification system of Felker et al 15 and their study includes only 2 cases of fulminant myocarditis treated with circulatory assist devices. Rockman et al reported that LV assist devices improve the prognosis of fulminant myocarditis, [20] [21] [22] but these devices require an operation performed by cardiovascular surgeons and are not suitable for emergency situations such as cardiac arrest or ventricular fibrillation. Therefore, we studied the long-term prognosis of the patients of fulminant myocarditis who required PCPS by comparing them with patients with acute myocarditis who did not required PCPS and our results strongly support the hypothesis that the long-term prognosis of patients of fulminant myocarditis who are treated by PCPS and survive the acute phase crisis is favorable. We also compared the echocardiographic features of fulminant myocarditis in patients who required PCPS and those patients who did not and found that certain geometric differences at presentation may predict subsequent recovery of ventricular function.
Study Limitations
The number of patients was relatively small and the lack of data for some aspects prevented a more detailed examination. It will be necessary to pursue the effect of PCPS on the long-term prognosis of fulminant myocarditis in more patients than were studied by us.
Conclusion
The long-term prognosis is favorable for patients who survive the acute phase crisis of fulminant myocarditis with mechanical support.
